None listed
Conditions
Sponsors
Honasa Consumer Pvt. Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1) Gender: Male and Female with age 18-45. 2) Subjects with dark and dull skin. 3) Subjects willing to give written informed consent 4) Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 5) Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 6) Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.
Exclusion criteria
Exclusion criteria: 1. Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition. 2. Have open sores or open lesions in the treatment area(s). 3. Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product. 4. Have participated in any interventional clinical trial in the previous 90 days. 5. Have a known sensitivity to any of the constituents of the test product including sensitivities to (mention some of active ingredient s name) 6. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids. 7. Have not skin related issues
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. change in Skin Brightness 2. Dermat evaluationTimepoint: At T0, T14, T28days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. change in Skin PigmentationTimepoint: At T0 , T7days, T14, T28days;1. change in Dark Spots 2. HD ImagingTimepoint: At T0 , T28days | — |
Countries
India
Contacts
Public ContactPuneet Mittal
CCFT Laboratories
Outcome results
None listed